These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 938493)

  • 1. The use of ninhydrin as a reagent for the reversible modification of arginine residues in proteins.
    Chaplin MF
    Biochem J; 1976 May; 155(2):457-9. PubMed ID: 938493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific modification of arginine residues in proteins with ninhydrin.
    Takahashi K
    J Biochem; 1976 Nov; 80(5):1173-6. PubMed ID: 826523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of hemoglobin by ninhydrin.
    Kokkini G; Stevens VJ; Peterson CM; Cerami A
    Blood; 1980 Oct; 56(4):701-5. PubMed ID: 7417710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of arginine in the reactive site of proteinase inhibitors by selective and reversible derivatization of the arginine side chain.
    Dietl T; Tschesche H
    Hoppe Seylers Z Physiol Chem; 1976 May; 357(5):657-65. PubMed ID: 964925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The study of ephedrine in drug mixtures. II. The ninhydrin reaction in the quantitative determination of ephedrine].
    Zobin A; Graczáné LM
    Acta Pharm Hung; 1975 May; 45(3):101-5. PubMed ID: 1130208
    [No Abstract]   [Full Text] [Related]  

  • 6. Camphorquinone-10-sulfonic acid and derivatives: convenient reagents for reversible modification of arginine residues.
    Pande CS; Pelzig M; Glass JD
    Proc Natl Acad Sci U S A; 1980 Feb; 77(2):895-9. PubMed ID: 6928687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the site of interaction for ninhydrin, alloxan, and D-glucose in insulin secretion by isolated islets in vitro.
    McDaniel ML; Bry CG; Fink CJ; Homer RW; Lacy PE
    Endocrinology; 1979 Dec; 105(6):1446-51. PubMed ID: 387386
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reactions of amino acids with ninhydrin and their applications].
    Dima F; Stefănescu E; Dorneanu V; Vasilescu M
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(3):507-9. PubMed ID: 3008288
    [No Abstract]   [Full Text] [Related]  

  • 9. High-performance liquid chromatographic analysis of guanidino compounds using ninhydrin reagent. II. Guanidino compounds in blood of patients on haemodialysis therapy.
    Hiraga Y; Kinoshita T
    J Chromatogr; 1985 Aug; 342(2):269-75. PubMed ID: 4055949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of rat liver glucokinase by alloxan and ninhydrin.
    Hara H; Miwa I; Okuda J
    Chem Pharm Bull (Tokyo); 1986 Nov; 34(11):4731-7. PubMed ID: 3829189
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical properties of anti-inflammatory drugs. IX. Uncoupling of oxidative phosphorylation and inhibition of a thiol enzyme (papain) by some cyclic beta-diones and ninhydrin.
    Whitehouse MW; Leader JE
    Biochem Pharmacol; 1967 Mar; 16(3):537-51. PubMed ID: 6040379
    [No Abstract]   [Full Text] [Related]  

  • 12. Reactions of papain and of low-molecular-weight thiols with some aromatic disulphides. 2,2'-Dipyridyl disulphide as a convenient active-site titrant for papain even in the presence of other thiols.
    Brocklehurst K; Little G
    Biochem J; 1973 May; 133(1):67-80. PubMed ID: 4721623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrophotometric determination of hydralazine hydrochloride tablets using ninhydrin.
    Dutt MC; Ng TL; Long LT
    J Assoc Off Anal Chem; 1983 Nov; 66(6):1455-7. PubMed ID: 6643357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An amplified assay for thiols based on reactivation of papain.
    Singh R; Blättler WA; Collinson AR
    Anal Biochem; 1993 Aug; 213(1):49-56. PubMed ID: 8238881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the chemical and catalytic characteristics of two crystallographically 'identical' enzyme catalytic sites. Characterization of actinidin and papain by a combination of pH-dependent substrate catalysis kinetics and reactivity probe studies targeted on the catalytic-site thiol group and its immediate microenvironment.
    Salih E; Malthouse JP; Kowlessur D; Jarvis M; O'Driscoll M; Brocklehurst K
    Biochem J; 1987 Oct; 247(1):181-93. PubMed ID: 2825655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A general framework of cysteine-proteinase mechanism deduced from studies on enzymes with structurally different analogous catalytic-site residues Asp-158 and -161 (papain and actinidin), Gly-196 (cathepsin B) and Asn-165 (cathepsin H). Kinetic studies up to pH 8 of the hydrolysis of N-alpha-benzyloxycarbonyl-L-arginyl-L-arginine 2-naphthylamide catalysed by cathepsin B and of L-arginine 2-naphthylamide catalysed by cathepsin H.
    Willenbrock F; Brocklehurst K
    Biochem J; 1985 Apr; 227(2):521-8. PubMed ID: 3890831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrophotometric determination of certain cephalosporins with ninhydrin.
    Mahrous MS; Abdel-Khalek MM
    Analyst; 1984 May; 109(5):611-3. PubMed ID: 6742444
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemical modification studies on arginine kinase: essential cysteine and arginine residues at the active site.
    Zhu WJ; Li M; Wang XY
    Int J Biol Macromol; 2007 Dec; 41(5):564-71. PubMed ID: 17765964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A spectrophotometric method for the detection of contaminant chymopapains in preparations of papain. Selective modification of one type of thiol group in the chymopapains by a two-protonic-state reagent.
    Baines BS; Brocklehurst K
    Biochem J; 1978 Jul; 173(1):345-7. PubMed ID: 687376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the papain active centre by using two-protonic-state electrophiles as reactivity probes. Evidence for nucleophilic reactivity in the un-interrupted cysteine-25-histidine-159 interactive system.
    Shipton M; Brochlehurst K
    Biochem J; 1978 May; 171(2):385-401. PubMed ID: 26335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.